BDBM107718 US8598210, Table XV, 24::US8722895, 24: ({3-Hydroxy-5-[3-(2H-tetrazol-5-yl)phenyl]- pyridine-2-carbonyl}-amino)-acetic acid

SMILES O=C(O)CNC(=O)c1ncc(-c2cccc(-c3nnn[nH]3)c2)cc1O

InChI Key InChIKey=JCWZYUTUSRZUAB-UHFFFAOYSA-N

Data  2 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 107718   

TargetEgl nine homolog 1(Human)
Akebia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 107718BDBM107718(US8722895, 24: ({3-Hydroxy-5-[3-(2H-tetrazol-5-yl)...)
Affinity DataIC50: 400nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
US Patent

TargetEgl nine homolog 1(Human)
Akebia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 107718BDBM107718(US8722895, 24: ({3-Hydroxy-5-[3-(2H-tetrazol-5-yl)...)
Affinity DataIC50: 400nMT: 2°CAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2014
Entry Details
US Patent

TargetVascular endothelial growth factor A(Human)
Akebia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 107718BDBM107718(US8722895, 24: ({3-Hydroxy-5-[3-(2H-tetrazol-5-yl)...)
Affinity DataEC50: >1.00E+5nMAssay Description:HEK293 cells are seeded in 96-well poly-lysine coated plates at 20,000 cells per well in DMEM (10% FBS, 1% NEAA, 0.1% glutamine). Following overnight...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2014
Entry Details
US Patent